Tomi F. Nano

Tomi F. Nano

Auto-generated profile, based on publicly available information

Tomi F. Nano

University of California, San Francisco (UCSF) Comprehensive Cancer Centre, San Francisco, CA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2020 in Medical Physics
Verified
Journal Article
Closed access
PDF file
TNTomi F. Nano
Tomi F. Nano
DCDante P. I. Capaldi
Dante P. I. Capaldi
TYTimothy Yeung
Timothy Yeung
CCCynthia F. Chuang
Cynthia F. Chuang
LWLei Wang
Lei Wang
MDMartina Descovich
Martina Descovich

23 November 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
GVGilmer Valdes
Gilmer Valdes
JSJessica Scholey
Jessica Scholey
TNTomi F. Nano
Tomi F. Nano
EGEfstathios D. Gennatas
Efstathios D. Gennatas
PMPranshu Mohindra
Pranshu Mohindra
CSCharles B. Simone
Charles B. Simone

4 June 2024 in Journal of Applied Clinical Medical Physics
Verified
Journal Article
Open access
PDF file
JSJess Scholey
Jess Scholey
TNTomi Nano
Tomi Nano
KSKamal Singhrao
Kamal Singhrao
OMOsama Mohammad
Osama Mohammad
LSLisa Singer
Lisa Singer
MDMartina Descovich
Martina Descovich
Purpose: CT Hounsfield Units (HUs) are converted to electron density using a calibration curve obtained from physical measurements of an electron density phantom. HU values assigned to an MRI‐derived synthetic computed tomography (sCT) may present a different relationship with electron density compared to CT HU. Correct assignment of sCT HU values is critical for accurate dose calculation and delivery. The goals of this work were to develop a sCT calibration curve using patient data acquired on a clinically commissioned CT scanner and assess for CyberKnife‐ and volumetric modulated arc therapy (VMAT)‐based MR‐only treatment planning of prostate SBRT.Methods: Same‐day CT and MRI simulation in the treatment position were performed on 10 patients treated with SBRT to the prostate. Dixon in‐phase and out‐of‐phase MRIs were acquired on a 3T scanner using a 3D T1‐weighted gradient‐echo sequence to generate sCTs using a commercial sCT algorithm. CT and sCT datasets were co‐registered and HU values compared using mean absolute error (MAE). An optimized HU‐to‐density calibration curve was created based on average HU values across an institutional patient database for each of the four sCT tissue types. Clinical CyberKnife and VMAT treatment plans were generated on each patient CT and recomputed onto corresponding sCTs. Dose distributions computed using CT and sCT were compared using gamma criteria and dose‐volume‐histograms.Results: For the optimized calibration curve, HU values were −96, 37, 204, and 1170 and relative electron densities were 0.95, 1.04, 1.1, and 1.7 for adipose, soft tissue, inner bone, and outer bone, respectively. The proposed sCT protocol produced total MAE of 94 ± 20HU. Gamma values mean ± std (min‐max) were 98.9% ± 0.9% (97.1%–100%) and 97.7% ± 1.3% (95.3%–99.3%) for VMAT and CyberKnife plans, respectively.Conclusion: MRI‐derived sCT using the proposed approach shows excellent dosimetric agreement with conventional CT simulation, demonstrating the feasibility of MRI‐derived sCT for prostate SBRT treatment planning.

3 December 2023 in Practical Radiation Oncology
Verified
Journal Article
Closed access
DCDante P.I. Capaldi
Dante P.I. Capaldi
MAMarian Axente
Marian Axente
AYAmy S. Yu
Amy S. Yu
NPNicolas D. Prionas
Nicolas D. Prionas
EHEmily Hirata
Emily Hirata
TNTomi F. Nano
Tomi F. Nano